Transcription factor C/EBPβ isoform ratio regulates osteoclastogenesis through MafB

Disequilibrium between bone‐forming osteoblasts and bone‐resorbing osteoclasts is central to many bone diseases. Here, we show that dysregulated expression of translationally controlled isoforms of CCAAT/enhancer‐binding protein β (C/EBPβ) differentially affect bone mass. Alternative translation initiation that is controlled by the mammalian target of rapamycin (mTOR) pathway generates long transactivating (LAP*, LAP) and a short repressive (LIP) isoforms from a single C/EBPβ transcript. Rapamycin, an inhibitor of mTOR signalling increases the ratio of LAP over LIP and inhibits osteoclastogenesis in wild type (WT) but not in C/EBPβ null (c/ebpβ−/−) or in LIP knock‐in (L/L) osteoclast precursors. C/EBPβ mutant mouse strains exhibit increased bone resorption and attenuated expression of MafB, a negative regulator of osteoclastogenesis. Ectopic expression of LAP and LIP in monocytes differentially affect the MafB promoter activity, MafB gene expression and dramatically affect osteoclastogenesis. These data show that mTOR regulates osteoclast formation by modulating the C/EBPβ isoform ratio, which in turn affects osteoclastogenesis by regulating MafB expression.

[1]  M. Baer,et al.  CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. , 1995, The EMBO journal.

[2]  Peter F. Johnson,et al.  Stop and Go: Anti-Proliferative and Mitogenic Functions of the Transcription Factor C/EBPβ , 2006, Cell cycle.

[3]  W. Xiong,et al.  Regulation of CCAAT/enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites. , 2001, Nucleic acids research.

[4]  S. Teitelbaum,et al.  Genetic regulation of osteoclast development and function , 2003, Nature Reviews Genetics.

[5]  D. Ramji,et al.  CCAAT/enhancer-binding proteins: structure, function and regulation. , 2002, The Biochemical journal.

[6]  T. Graf,et al.  MafB Is an Interaction Partner and Repressor of Ets-1 That Inhibits Erythroid Differentiation , 1996, Cell.

[7]  T. Golub,et al.  A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.

[8]  L. Xing,et al.  Future Anti‐Catabolic Therapeutic Targets in Bone Disease , 2006, Annals of the New York Academy of Sciences.

[9]  A. Leutz,et al.  Essential Requirement of CCAAT/Enhancer Binding Proteins in Embryogenesis , 2004, Molecular and Cellular Biology.

[10]  B. Porse,et al.  Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo. , 2007, The EMBO journal.

[11]  C. Nerlov.  The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. , 2007, Trends in cell biology.

[12]  V. Everts,et al.  Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts , 2006, Journal of cellular biochemistry.

[13]  K. A. Wilson,et al.  Col1a1 Promoter-targeted Expression of p20 CCAAT Enhancer-binding Protein β (C/EBPβ), a Truncated C/EBPβ Isoform, Causes Osteopenia in Transgenic Mice* , 2005, Journal of Biological Chemistry.

[14]  Peter F. Johnson,et al.  Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors , 2005, Journal of Cell Science.

[15]  G. Stein,et al.  Chromatin Remodeling and Transcriptional Activity of the Bone-specific Osteocalcin Gene Require CCAAT/Enhancer-binding Protein β-dependent Recruitment of SWI/SNF Activity* , 2006, Journal of Biological Chemistry.

[16]  R. Pereira,et al.  CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia. , 2007, Bone.

[17]  T. Graf,et al.  MafB deficiency causes defective respiratory rhythmogenesis and fatal central apnea at birth , 2003, Nature Neuroscience.

[18]  Seoung-Hoon Lee,et al.  NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). , 2008, Molecular endocrinology.

[19]  G. Barsh,et al.  The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor , 1994, Cell.

[20]  H. Nakabayashi,et al.  Molecular cloning and functional characterization of the mouse mafB gene. , 2000, Gene.

[21]  T. Yoneda,et al.  A CCAAT/Enhancer Binding Protein β Isoform, Liver-Enriched Inhibitory Protein, Regulates Commitment of Osteoblasts and Adipocytes , 2005, Molecular and Cellular Biology.

[22]  R. Cortese,et al.  Lymphoproliferative disorder and imbalanced T‐helper response in C/EBP beta‐deficient mice. , 1995, The EMBO journal.

[23]  Nobuaki Yoshida,et al.  Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages , 1995, Cell.

[24]  C. Murphy,et al.  TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. , 2002, Endocrinology.

[25]  V. Everts,et al.  Effect of CD44 deficiency on in vitro and in vivo osteoclast formation , 2005, Journal of cellular biochemistry.

[26]  M. Helfrich.  Osteoclast diseases , 2003, Microscopy research and technique.

[27]  O. MacDougald,et al.  Adipocyte differentiation from the inside out , 2006, Nature Reviews Molecular Cell Biology.

[28]  A. Uitterlinden,et al.  The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Graf,et al.  MafB is an inducer of monocytic differentiation , 2000, The EMBO journal.

[30]  G. Gronowicz,et al.  Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. , 2005, The Journal of biological chemistry.

[31]  Achim Leutz,et al.  Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain. , 2005, Genes & development.

[32]  G. Roodman,et al.  The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma , 2005, Immunological reviews.

[33]  S. Akira,et al.  CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. , 2008, Molecular biology of the cell.

[34]  B. Dörken,et al.  A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas. , 2005, Blood.

[35]  S. Akira,et al.  IL‐6 and NF‐IL6 in Acute‐Phase Response and Viral Infection , 1992, Immunological reviews.

[36]  G. Barsh,et al.  The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. , 2002, Developmental biology.

[37]  L. Glimcher,et al.  NFATc1 and NFATc2 together control both T and B cell activation and differentiation. , 2001, Immunity.

[38]  E. Medrano,et al.  HDAC1 Promotes Liver Proliferation in Young Mice via Interactions with C/EBPβ* , 2008, Journal of Biological Chemistry.

[39]  D. Ron,et al.  C/EBP homologous protein is necessary for normal osteoblastic function , 2006, Journal of cellular biochemistry.

[40]  A. Leutz,et al.  Translational control of C/EBPalpha and C/EBPbeta isoform expression. , 2000, Genes & development.

[41]  Y. Toyama,et al.  DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells , 2005, The Journal of experimental medicine.

[42]  C. Murphy,et al.  TNFα Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL. , 2002, Endocrinology.

[43]  Gideon A. Rodan,et al.  Control of osteoblast function and regulation of bone mass , 2003, Nature.

[44]  Laurent Vanhille,et al.  Development of Macrophages with Altered Actin Organization in the Absence of MafB , 2006, Molecular and Cellular Biology.

[45]  Y. Umayahara,et al.  CCAAT/Enhancer-binding Protein δ Is a Critical Regulator of Insulin-like Growth Factor-I Gene Transcription in Osteoblasts* , 1999, The Journal of Biological Chemistry.

[46]  A. Leutz,et al.  Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression. , 1994, Genes & development.

[47]  S. Akira,et al.  Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. , 1997, The EMBO journal.

[48]  Achim Leutz,et al.  A C/EBPβ Isoform Recruits the SWI/SNF Complex to Activate Myeloid Genes , 1999 .

[49]  Jiake Xu,et al.  Interaction between osteoblast and osteoclast: impact in bone disease. , 2004, Histology and histopathology.

[50]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[51]  U. Schibler,et al.  A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the sam mRNA , 1991, Cell.

[52]  Michael C. Ostrowski,et al.  NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. , 2008, The Journal of clinical investigation.

[53]  S. Takeshita,et al.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. , 2000, The Journal of clinical investigation.

[54]  Valeria Poli,et al.  The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions* , 1998, The Journal of Biological Chemistry.

[55]  Peter F. Johnson,et al.  CCAAT/Enhancer Binding Protein β Is a Neuronal Transcriptional Regulator Activated by Nerve Growth Factor Receptor Signaling , 1998 .

[56]  Hiroshi Takayanagi,et al.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. , 2002, Developmental cell.

[57]  A. Miyawaki,et al.  Differential Contribution of NFATc2 and NFATc1 to TNF-α Gene Expression in T Cells1 , 2008, The Journal of Immunology.

[58]  E. Sterneck,et al.  CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling. , 1998, Journal of neurochemistry.

[59]  D. Durant,et al.  Misexpression of CCAAT/enhancer binding protein beta causes osteopenia. , 2009, The Journal of endocrinology.

[60]  S. Akira,et al.  The C/EBPβ Isoform 34-kDa LAP Is Responsible for NF-IL-6-Mediated Gene Induction in Activated Macrophages, but Is Not Essential for Intracellular Bacteria Killing1 , 2007, The Journal of Immunology.

[61]  A. Leutz,et al.  A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. , 1999, Molecular cell.

[62]  J. D. Engel,et al.  MafB Is Essential for Renal Development and F4/80 Expression in Macrophages , 2006, Molecular and Cellular Biology.

[63]  K. Akashi,et al.  C/EBPbeta is required for 'emergency' granulopoiesis. , 2006, Nature immunology.

[64]  L. Tessarollo,et al.  An essential role for C/EBPbeta in female reproduction. , 1997, Genes & development.

[65]  G. Wesolowski,et al.  M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase , 2003, Cell Death and Differentiation.

[66]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[67]  S. Akira,et al.  CCAAT/Enhancer-Binding Protein Homologous Protein (CHOP) Regulates Osteoblast Differentiation , 2006, Molecular and Cellular Biology.

[68]  H. Lane,et al.  Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. , 2004, Bone.

[69]  T. Martin,et al.  Osteoclast-derived activity in the coupling of bone formation to resorption. , 2005, Trends in molecular medicine.

[70]  Soo Young Lee,et al.  MafB negatively regulates RANKL-mediated osteoclast differentiation. , 2007, Blood.

[71]  T. Martin,et al.  Therapeutic approaches to bone diseases. , 2000, Science.

[72]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[73]  B. Porse,et al.  Distinct C/EBPα motifs regulate lipogenic and gluconeogenic gene expression in vivo , 2007 .

[74]  K. Akashi,et al.  Induction of granulocytic differentiation by 2 pathways. , 2002, Blood.

[75]  G. Stein,et al.  CCAAT/Enhancer-binding Proteins (C/EBP) β and δ Activate Osteocalcin Gene Transcription and Synergize with Runx2 at the C/EBP Element to Regulate Bone-specific Expression* , 2002, The Journal of Biological Chemistry.

[76]  E. Wagner,et al.  Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 , 2000, Nature Medicine.

[77]  Achim Leutz,et al.  Translational control of gene expression and disease. , 2002, Trends in molecular medicine.

[78]  Tak W. Mak,et al.  Autoamplification of NFATc1 expression determines its essential role in bone homeostasis , 2005, The Journal of experimental medicine.

[79]  S. Akira,et al.  Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene , 1997 .

[80]  E. Schwarz,et al.  Efficacy of Etanercept for Wear Debris‐Induced Osteolysis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[81]  A. Miyawaki,et al.  Differential contribution of NFATc2 and NFATc1 to TNF-alpha gene expression in T cells. , 2008, Journal of immunology.